Insider · CIK 0001320490
Steven H Nelson
Files at CVS (CVS HEALTH Corp), HCAT (Health Catalyst, Inc.). First filing Jan 27, 2026, latest Jan 27, 2026.
In brief
Steven H Nelson files SEC Form 4 as officer and director at CVS (CVS HEALTH Corp), and also at HCAT (Health Catalyst, Inc.). Since Jan 27, 2026, Steven H Nelson has reported 1 open-market buy worth $1,289 and 0 open-market sells worth $0, the latest filed on Jan 27, 2026.
A track record needs three past buys with six months of prices behind them; Steven H Nelson has 0, so none is measured yet.
The newest scored trade: bought $1,289 of CVS on Jan 23, 2025, filed Jan 27, 2026, scored 27 (weak). In the last 12 months: 1 buy worth $1,289 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CVS: CVS HEALTH Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | CVSbuy CVS HEALTH Corp | $1,289 24 shares | - | +25% from low-18% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +80,691 | $0.00 | $0 | 235,499 | Jul 20, 2026 |
| May 1, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +154,808 | $0.00 | $0 | 154,808 | May 4, 2026 |
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Common Stock (Restricted) | +22,277 | $71.82 | $1.6M | 43,606 | Apr 2, 2026 |
| Apr 1, 2026 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -2,432 | $72.49 | $176k | 2,900 | Apr 2, 2026 |
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Stock Optionderivative | +143,712 | $71.82 | $10M | 143,712 | Apr 2, 2026 |
| Jan 23, 2025 | CVS CVS HEALTH Corp | POpen-market purchase Common Stock (By Trust)indirect: By Trust | +24 | $53.70 | $1,289 | 24 | Jan 27, 2026 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | AGrant or award Common Stock (Restricted) | +21,329 | $67.98 | $1.4M | 21,329 | Apr 3, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | AGrant or award Stock Optionderivative | +90,455 | $67.98 | $6.1M | 90,455 | Apr 3, 2025 |
| Nov 30, 2024 | CVS CVS HEALTH Corp | AGrant or award Premium Stock Optionderivative | +124,378 | $71.82 | $8.9M | 124,378 | Dec 3, 2024 |
Questions about Steven H Nelson
Answered from the filings on this page, as of the latest one.
Is Steven H Nelson buying or selling?
In the last 12 months Steven H Nelson reported 1 open-market buy worth $1,289 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1,289 of CVS on Jan 23, 2025. Grants, option exercises and tax withholding are not counted.
How did Steven H Nelson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven H Nelson has 0.
Where does Steven H Nelson file Form 4?
Steven H Nelson has filed Form 4 at CVS (CVS HEALTH Corp) as EVP and President, Aetna; HCAT (Health Catalyst, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.